Platform Technology Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$525K Buy
10,941
+3,079
+39% +$132K 0.09% 179
2026
Q1
$289K Hold
7,862
– – 0.06% 233
2025
Q4
$400K Buy
7,862
+484
+7% +$24.8K 0.09% 173
2025
Q3
$409K Sell
7,378
-182
-2% -$10.7K 0.1% 161
2025
Q2
$522K Buy
7,560
+800
+12% +$54.4K 0.14% 145
2025
Q1
$469K Buy
6,760
+1,083
+19% +$89.4K 0.14% 140
2024
Q4
$488K Buy
5,677
+1,584
+39% +$171K 0.15% 123
2024
Q3
$487K Hold
4,093
– – 0.15% 124
2024
Q2
$584K Buy
+4,093
New +$542K 0.2% 107
2023
Q4
$503K Sell
4,175
-33
-0.8% -$3.26K 0.2% 113
2023
Q3
$383K Buy
4,208
+488
+13% +$43K 0.18% 121
2023
Q2
$283K Sell
3,720
-656
-15% -$53.6K 0.13% 153
2023
Q1
$348K Buy
4,376
+724
+20% +$51.3K 0.17% 134
2022
Q4
$247K Buy
+3,652
New +$214K 0.13% 158
2022
Q3
– Sell
-3,756
Closed -$209K – 207
2022
Q2
$209K Buy
3,756
+134
+4% +$7.44K 0.11% 167
2022
Q1
$201K Hold
3,622
– – 0.1% 180
2021
Q4
$203K Sell
3,622
-8,724
-71% -$473K 0.09% 192
2021
Q3
$593K Hold
12,346
– – 0.27% 99
2021
Q2
$517K Buy
+12,346
New +$479K 0.21% 124
2020
Q4
$431K Buy
12,346
+640
+5% +$22.1K 0.21% 124
2020
Q3
$406K Hold
11,706
– – 0.25% 104
2020
Q2
$383K Sell
11,706
-1,130
-9% -$36.1K 0.27% 104
2020
Q1
$386K Sell
12,836
-60
-0.5% -$1.79K 0.35% 86
2019
Q4
$373K Buy
+12,896
New +$357K 0.28% 109

Other funds holding NVO

Platform Technology Partners's NVO Position: Q2 2026 in Review

Platform Technology Partners increased its Novo Nordisk (NVO) stake by 39% in Q2 2026, buying an estimated $132K and bringing the position to 10,941 shares worth $525K. The position accounts for 0.09% of the portfolio, ranked #179.

Platform Technology Partners first reported a position in NVO in Q4 2019 and has held it in 24 quarters since. The position peaked at $593K in Q3 2021. 1,357 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Platform Technology Partners held 10,941 shares of Novo Nordisk worth $525K as of Q2 2026.
  • Platform Technology Partners bought 3,079 Novo Nordisk shares in Q2 2026, an estimated $132K.
  • Novo Nordisk made up 0.09% of Platform Technology Partners's portfolio in Q2 2026, its #179 holding.
  • Platform Technology Partners first reported a position in Novo Nordisk in Q4 2019 and has held it in 24 quarters since.
  • Platform Technology Partners's Novo Nordisk position peaked at $593K in Q3 2021.
  • 1,357 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.